2Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome,clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum, 2002, 46:1019-1027.
3Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med, 1994, 96: 3-9.
4Avcin T, Cimas R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.Lupus, 2002, 11: 4-10.
5Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol,2002,47: 215-238.
6Rai R, Cohen H, Dave M, et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ, 1997,314: 253-257.
7Juanola X, Mateo L, Domenech P, et al. Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis. J Rheumatol, 1995, 22:1891-1893.
8Deleze M, Alarcon-Segnvia D, Oria CM, et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol, 1989, 16: 926-930.
9Cuadrado MJ, Mujic F, Munoz E, et al. Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis, 1997, 56:194-196.
10Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum, 2003
